Medication info
Wilpidin Tablets (Cimetidine)

Wilpidin Tablets (Cimetidine)

Prescription medicationTablet
Ingredient · strength
Cimetidine›200mg / 1 tablet
Manufacturer / importer
iWorld Pharmaceutical Co., Ltd.
Appearance
Dark green round film-coated tablets
Packaging
600 tablets/bottle
Approval status
Active

MFDS item code 201307937 · Approved 2013.06.28

Summary

Main use
Treatment of acid-related disorders (e.g., ulcers and gastroesophageal reflux disease) and improvement of gastric mucosal lesions associated with gastritis
Who uses it
Adults · Children
Adult dosage
Adults: Administer cimetidine 400 mg orally twice daily (in the morning and at bedtime), or 800 mg once daily (at bedtime). Alternatively, administer 300 mg orally 4 times daily (after meals and at bedtime). The dose may be increased to 400 mg 4 times daily (after meals and at bedtime) (total 1.6 g). However, for improvement of gastric mucosal lesions (erosion, bleeding, redness, edema) associated with the following conditions: acute gastritis and acute exacerbation of chronic gastritis, administer 200 mg twice daily or 400 mg once daily. An antacid may be administered as needed for pain relief. Since the dose may be increased depending on the patient, increase the frequency of administration rather than the dose per administration. Do not exceed 2.4 g per day. Patients with renal insufficiency: Administer 300 mg of this drug twice daily, every 12 hours. If necessary, depending on the patient's symptoms, the frequency may be increased to 3 times daily, every 8 hours, or more often, but use caution. In patients with severe renal insufficiency, the drug may accumulate in the body, so reduce the frequency of administration to a minimum according to the patient's response. Hemodialysis lowers the blood cimetidine level. After hemodialysis is completed, administer the drug again according to the schedule. Adjust the dose appropriately according to age and symptoms.
Children's dosage
Children: Administer 20 〜 40 mg/kg of body weight per day orally in divided doses.

Ingredients

Manufacturer
iWorld Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (e.g., ulcers and gastroesophageal reflux disease) and improvement of gastric mucosal lesions associated with gastritis

  • Gastric and duodenal ulcers
  • gastroesophageal reflux disease
  • recurrent ulcers
  • anastomotic ulcers
  • Zollinger-Ellison syndrome
  • gastric mucosal lesions
  • erosion
  • bleeding
  • redness
  • swelling
  • acute gastritis
  • acute exacerbation of chronic gastritis
View approved original text

This medication is used to treat diseases such as gastric and duodenal ulcers, gastroesophageal reflux disease, recurrent ulcers, anastomotic ulcers, and Zollinger-Ellison syndrome. It also helps improve symptoms such as erosion, bleeding, redness, and swelling of the gastric mucosa that occur during acute exacerbations of acute and chronic gastritis. This medication aids in the recovery of gastric mucosal damage and alleviates symptoms, thus enhancing the quality of life for patients. Therefore, it works effectively across a wide range of gastrointestinal diseases to improve patients' health.

Dosage and Administration

Adult dosage

Adults: Administer cimetidine 400 mg orally twice daily (in the morning and at bedtime), or 800 mg once daily (at bedtime). Alternatively, administer 300 mg orally 4 times daily (after meals and at bedtime). The dose may be increased to 400 mg 4 times daily (after meals and at bedtime) (total 1.6 g). However, for improvement of gastric mucosal lesions (erosion, bleeding, redness, edema) associated with the following conditions: acute gastritis and acute exacerbation of chronic gastritis, administer 200 mg twice daily or 400 mg once daily. An antacid may be administered as needed for pain relief. Since the dose may be increased depending on the patient, increase the frequency of administration rather than the dose per administration. Do not exceed 2.4 g per day. Patients with renal insufficiency: Administer 300 mg of this drug twice daily, every 12 hours. If necessary, depending on the patient's symptoms, the frequency may be increased to 3 times daily, every 8 hours, or more often, but use caution. In patients with severe renal insufficiency, the drug may accumulate in the body, so reduce the frequency of administration to a minimum according to the patient's response. Hemodialysis lowers the blood cimetidine level. After hemodialysis is completed, administer the drug again according to the schedule. Adjust the dose appropriately according to age and symptoms.

Children's dosage

Children: Administer 20 〜 40 mg/kg of body weight per day orally in divided doses.

Precautions

Care must be taken when cutting the container to use this medication, as glass fragments may be mixed in when using an ampoule injection. Special caution is needed when administering to children or the elderly. Patients who have hypersensitivity to this medication or have had allergies to this medication or its ingredients, as well as patients currently taking dofetilide, should not use this medication. The risk of arrhythmia may increase when used with dofetilide. Patients with poor kidney or liver functions, those with a history of allergic reactions to medication, elderly patients, children under 19 years of age, and patients undergoing hemodialysis should use this medication with caution, adjusting the dosage or extending the administration intervals as necessary. Additionally, symptoms of stomach cancer may be concealed, so it is important to check for malignancy before use, and patients with Helicobacter pylori infection may require eradication therapy. During the course of treatment, various adverse reactions may occur, such as decreased blood cell counts, liver dysfunction, kidney dysfunction, hypersensitivity reactions, hormone-related side effects, gastrointestinal symptoms, neurological symptoms, cardiac rhythm abnormalities, and serious skin reactions. If any abnormal symptoms appear, the healthcare provider should be notified immediately. During treatment, it is essential to carefully observe the course of the illness and use only the minimum effective dose; if there is no effect, the treatment should be changed to another method. Special caution is required when elderly or chronic disease patients take this medication alongside non-steroidal anti-inflammatory drugs. This medication may interact with several other drugs, so when taken with warfarin, midazolam, diazepam, beta-blockers, antiepileptics, antiarrhythmics, antidepressants, antifungals, adjustments in dosage or withdrawal periods may be necessary. Women who are pregnant or may become pregnant should carefully consider the benefits and risks of using this medication, and breastfeeding should be discontinued if nursing. Safety has not been sufficiently confirmed for use in children, so it should only be used if absolutely necessary; elderly patients may require dose adjustments due to decreased renal function, potentially leading to increased blood concentrations. In case of overdose, severe symptoms such as respiratory depression may occur, requiring immediate emergency treatment. When used as an injection, rapid intravenous administration may cause arrhythmias or hypotension, so it must be administered slowly. This medication should be kept out of reach of children, and transferring it to other containers should be avoided as it may compromise quality.

Side effects

  • Leukopenia
  • neutropenia
  • agranulocytosis
  • thrombocytopenia
  • pancytopenia
  • aplastic anemia
  • generalized weakness
  • asthenia
  • subcutaneous bleeding
  • mucosal bleeding
Show 60 more
  • fever
  • immune hemolytic anemia
  • jaundice
  • hepatitis
  • elevated AST
  • elevated ALT
  • liver dysfunction
  • liver fibrosis
  • interstitial seizures
  • acute renal failure
  • interstitial nephritis
  • urinary retention
  • elevated BUN
  • elevated serum creatinine
  • shock
  • anaphylaxis-like reaction
  • generalized rash
  • dyspnea
  • hypersensitivity vasculitis
  • rash
  • gynecomastia
  • galactorrhea
  • increased leukorrhea
  • erectile dysfunction
  • abdominal distension
  • constipation
  • diarrhea
  • headache
  • dizziness
  • convulsion
  • limb numbness
  • rigidity
  • drowsiness
  • hypochondriacal symptoms
  • impaired consciousness
  • delirium
  • agitation
  • psychosis
  • depression
  • excitation
  • hallucination
  • loss of direction
  • bradycardia
  • tachycardia
  • palpitations
  • heart block
  • skin and mucous membrane syndrome
  • toxic epidermal necrosis
  • epidermal necrosis
  • erythema multiforme
  • exfoliative dermatitis
  • generalized exfoliative erythema
  • fatigue
  • generalized heat sensation
  • dysuria
  • myalgia
  • arthralgia
  • pancreatitis
  • hair loss
  • polymyositis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air or moisture from entering, and it is best to keep it at room temperature between 1 degree to 30 degrees Celsius. Proper storage will maintain the effectiveness of the medication and ensure safe use.

Appearance and packaging

Appearance

Dark green round film-coated tablets

Package unit

600 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.